- Home
- CAKE vs IMCR Comparison
CAKE vs IMCR Comparison
Compare CAKE & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAKE
- IMCR
- Stock Information
- Founded
- CAKE 1972
- IMCR 2008
- Country
- CAKE United States
- IMCR United Kingdom
- Employees
- CAKE N/A
- IMCR N/A
- Industry
- CAKE Restaurants
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CAKE Consumer Discretionary
- IMCR Health Care
- Exchange
- CAKE Nasdaq
- IMCR Nasdaq
- Market Cap
- CAKE 2.8B
- IMCR 1.5B
- IPO Year
- CAKE 1992
- IMCR 2021
- Fundamental
- Price
- CAKE $65.70
- IMCR $32.80
- Analyst Decision
- CAKE Hold
- IMCR Buy
- Analyst Count
- CAKE 14
- IMCR 10
- Target Price
- CAKE $53.50
- IMCR $58.13
- AVG Volume (30 Days)
- CAKE 1.4M
- IMCR 444.9K
- Earning Date
- CAKE 07-30-2025
- IMCR 08-07-2025
- Dividend Yield
- CAKE 1.64%
- IMCR N/A
- EPS Growth
- CAKE 45.67
- IMCR N/A
- EPS
- CAKE 3.19
- IMCR N/A
- Revenue
- CAKE $3,617,673,000.00
- IMCR $333,581,000.00
- Revenue This Year
- CAKE $7.04
- IMCR $26.82
- Revenue Next Year
- CAKE $6.10
- IMCR $8.15
- P/E Ratio
- CAKE $20.61
- IMCR N/A
- Revenue Growth
- CAKE 4.42
- IMCR 25.75
- 52 Week Low
- CAKE $33.50
- IMCR $23.15
- 52 Week High
- CAKE $65.99
- IMCR $41.54
- Technical
- Relative Strength Index (RSI)
- CAKE 78.81
- IMCR 51.47
- Support Level
- CAKE $59.16
- IMCR $30.76
- Resistance Level
- CAKE $61.21
- IMCR $33.95
- Average True Range (ATR)
- CAKE 1.73
- IMCR 1.39
- MACD
- CAKE 0.44
- IMCR -0.15
- Stochastic Oscillator
- CAKE 96.98
- IMCR 43.05
About CAKE Cheesecake Factory Incorporated (The)
Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.